{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:25:30Z","timestamp":1767666330011},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1980,5,1]],"date-time":"1980-05-01T00:00:00Z","timestamp":325987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1980,5]]},"DOI":"10.1007\/bf01639592","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T00:33:04Z","timestamp":1115425984000},"page":"S261-S267","source":"Crossref","is-referenced-by-count":7,"title":["In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria"],"prefix":"10.1007","volume":"8","author":[{"given":"A.","family":"DeMaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. R.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. O.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. R.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1980,5,1]]},"reference":[{"key":"BF01639592_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1128\/AAC.16.2.141","volume":"16","author":"H. C. Neu","year":"1979","unstructured":"Neu, H. C., Aswapokee, N., Fu K. P., Aswapokee, P. Antibacterial activity of a new 1-oxa-cephalosporin compared with that of other \u03b2-lactam compounds. Antimicrob. Agents Chemother. 16 (1979) 141\u2013149.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1128\/AAC.16.3.287","volume":"16","author":"M. Barza","year":"1979","unstructured":"Barza, M., Tally, F. P., Jacobus, N. V., Gorbach, S. L. In vitro activity of LY127935. Antimicrob. Agents Chemother. 16 (19790 287\u2013292.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/AAC.17.3.302","volume":"17","author":"T. Yoshida","year":"1980","unstructured":"Yoshida, T., Matsuura, S., Mayama, M., Kameda, Y., Kuwahara, S. Moxalactam (6059-S), a novel 1-oxa-\u03b2-lactam with an expanded antibacterial spectrum: Laboratory evaluation. Antimicrob. Agents Chemother. 17 (1980) 302\u2013312.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.7164\/antibiotics.32.909","volume":"32","author":"K. P. Fu","year":"1979","unstructured":"Fu, K. P., Neu, H. C. The comparative \u03b2-lactamase resistance and inhibitory activity of 1-oxa-cephalosporin, cefoxitin and cefotaxime. J. Antibiot. (Tokyo) 32 (1979) 909\u2013914.","journal-title":"J. Antibiot."},{"key":"BF01639592_CR5","first-page":"110","volume-title":"Current chemotherapy and infectious disease","author":"J. Kurihara","year":"1980","unstructured":"Kurihara, J., Matsumoto, K., Uzuka, Y., Shishido, H., Nagatake, T., Yamada, M., Yoshida, T., Oguma, T., Kimura, Y., Tochino, Y. Human pharmacokinetics of 6059-S. In:Nelson, J. D., Grassi, C. (ed.): Current chemotherapy and infectious disease. American Society for Microbiology, Washington, D. C., 1980, pp. 110\u2013111."},{"key":"BF01639592_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1128\/AAC.17.2.226","volume":"17","author":"J. W. Parsons","year":"1980","unstructured":"Parsons, J. W., Romano, J. M., Levison, M. E. Pharmacology of a new 1-oxa-\u03b2-lactam (LY127935) in normal volunteers. Antimicrob. Agents Chemother. 17 (1980) 226\u2013228.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR7","first-page":"307","volume":"9","author":"E. E. Steers","year":"1959","unstructured":"Steers, E. E., Foltz, E. L., Graves, B. S., Riden, J. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. 9 (1959) 307\u2013311.","journal-title":"Antibiot. Chemother."},{"key":"BF01639592_CR8","doi-asserted-by":"crossref","unstructured":"Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Turck, M.: Antibiotic susceptibility testing by a standard single disc method. Am. J. Clin. Pathol. (1966) 493\u2013496.","DOI":"10.1093\/ajcp\/45.4_ts.493"},{"key":"BF01639592_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1128\/AAC.16.3.341","volume":"16","author":"R. Wise","year":"1979","unstructured":"Wise, R., Andrews, J. M., Bedford, K. A. LY127935, a novel oxa-\u03b2-lactam: An in vitro comparison with other \u03b2-lactam antibiotics. Antimicrob. Agents Chemother. 16 (1979) 341\u2013345.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/BF01640785","volume":"5","author":"W. E. Farrar","year":"1977","unstructured":"Farrar, W. E., O'Dell, N. M. Beta-lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli. Infection 5 (1977) 224\u2013227.","journal-title":"Infection"},{"issue":"Suppl.","key":"BF01639592_CR11","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/infdis\/137.Supplement.S38","volume":"137","author":"K. P. Fu","year":"1978","unstructured":"Fu, K. P., Neu, H. C. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the \u03b2-lactamase stability and synergy of cefamandole with aminoglycosides. J. Infect. Dis. 137 Suppl. (1978) S38-S48.","journal-title":"J. Infect. Dis."},{"key":"BF01639592_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/AAC.15.1.14","volume":"15","author":"J. L. Ott","year":"1979","unstructured":"Ott, J. L., Turner, J. R., Mahoney, D. F. Lack of correlation between \u03b2-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants ofEnterobacteriaceae. Antimicrob. Agents Chemother. 15 (1979) 14\u201319.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1128\/AAC.16.6.864","volume":"16","author":"D. G. Delgado","year":"1979","unstructured":"Delgado, D. G., Brau, C. J., Cobbs, C. G., Dismukes, W. E. In vitro activity of LY127935, a new 1-oxa-cephalosporin, against aerobic gram-negative bacilli. Antimicrob. Agents Chemother. 16 (1979) 864\u2013868.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1128\/AAC.16.5.641","volume":"16","author":"D. J. Flournoy","year":"1979","unstructured":"Flournoy, D. J., Perryman, F. A. LY127935, a new beta-lactam antibiotic, versusProteus, Klebsiella, Serratia andPseudomonas. Antimicrob. Agents Chemother. 16 (1979) 642\u2013643.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/AAC.16.4.503","volume":"16","author":"R. J. Fass","year":"1979","unstructured":"Fass, R. J. In vitro activity of LY127935. Antimicrob. Agents Chemother. 16 (1979) 503\u2013509.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1128\/AAC.17.2.273","volume":"17","author":"W. H. Hall","year":"1980","unstructured":"Hall, W. H., Opfer, B. J., Gerding, D. N. Comparative activities of the oxa-\u03b2-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Antimicrob. Agents Chemother. 17 (1980) 273\u2013279.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01639592_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1128\/AAC.17.3.488","volume":"17","author":"S. D. R. Lang","year":"1980","unstructured":"Lang, S. D. R., Edwards, D. J., Durack, D. T. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob. Agents Chemother. 17 (1980) 488\u2013493.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01639592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01639592\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01639592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01639592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:57:10Z","timestamp":1557255430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01639592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,5]]},"references-count":17,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1980,5]]}},"alternative-id":["BF01639592"],"URL":"https:\/\/doi.org\/10.1007\/bf01639592","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,5]]}}}